Table 1. Basic characteristics of patients (n=113).
| Characteristics | RH group | CCRT group | P-value | |
|---|---|---|---|---|
| No. | 64 (56.6) | 49 (43.4) | - | |
| Adjuvant therapya) | 38 (59.4) | 3 (6.1) | - | |
| Age at diagnosis (yr) | 46.1±11.0 | 54.8±11.6 | <0.001 | |
| Comorbid medical diseaseb) | 0.066 | |||
| Yes | 6 (9.3) | 11 (22.4) | ||
| No | 58 (90.7) | 38 (77.6) | ||
| FIGO staging | 0.019 | |||
| IB2 | 45 (70.3) | 23 (46.9) | ||
| IIA | 19 (29.7) | 26 (53.1) | ||
| Histologic classification | 0.595 | |||
| Squamous cell carcinoma | 49 (76.6) | 41 (83.7) | ||
| Adenocarcinoma | 10 (15.6) | 6 (12.2) | ||
| Adenosquamous cell carcinoma | 5 (7.8) | 2 (5.2) | ||
| Maximum tumor diameter in MRI (mm) | 32.1±2.0 | 39.6±2.6 | 0.020 | |
| <40 | 38 (59.4) | 20 (40.8) | 0.004 | |
| 40–60 | 26 (40.6) | 23 (46.9) | - | |
| >60 | 0 (0.0) | 6 (12.2) | - | |
| Lymph nodal status in MRI | <0.001 | |||
| Positive | 11 (17.2) | 27 (55.1) | ||
| Negative | 53 (82.8) | 22 (44.9) | ||
| Parametrial invasion status in MRI | 0.013 | |||
| Positive | 9 (14.1) | 17 (34.7) | ||
| Negative | 55 (85.9) | 32 (65.3) | ||
Data are presented as number (%) or mean±standard deviation.
RH, radical hysterectomy; CCRT, concurrent chemoradiation therapy; FIGO, International Federation of Obstetrics Gynecology; MRI, magnetic resonance imaging; RT, radiation therapy.
a)Adjuvant therapy: RT or CCRT in RH group/type I hysterectomy in CCRT group; b)Comorbid medical disease: hypertension, diabetes mellitus, medical thyroid disease, stroke, myocardial infarction, chronic liver disease.